Published Research

Body:

Kritz S, Brown LS, Goldsmith RJ, Bini EJ, Robinson J, Alderson D, Novo P, Rotrosen J
States and Substance Abuse Treatment Programs: Funding and Guidelines for Infection-Related Services American Journal of Public Health (2008) 98:824-6. PMC 2374831
Publication

Body:

Carroll KM, Rosa C, Brown LS, Dawd R, Magruder KM, Beatty L
Addressing ethnic disparities in drug abuse treatment in the clinical trials network Drug and Alcohol Dependence (2007) 90: 101-6.
Publication

Body:

Sorensen JL, Brown LS, Calsyn D, Tross S, Booth RE, Songa Y, Normand J
AIDS research in the NIDA Clinical Trials Network: Emerging results Drug and Alcohol Dependence (2007) 89: 310-13.
Publication

Body:

Brown LS, Kritz S, Goldsmith RJ, Bini EJ, Robinson J, Alderson D, Rotrosen J
Health Services for HIV/AIDS, HCV, and Sexually Transmitted Infections in Substance Abuse Treatment Programs Public Health Reports (2007) 122:441-51. PMC 1888517
Publication

Body:

Brown LS, Kritz S, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, Robinson J
Characteristics of Substance Abuse Treatments Programs Providing Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections: the National Drug Abuse Treatment Clinical Trials Network Journal of Substance Abuse Treatment (2006) 30:315-21. PMC 2535811
Publication

Body:

Brown LS, Kritz S, Chu M, Madray C
Safety, Efficacy, and Tolerability of Nelfinavir Containing Antiretroviral Therapy for Patients on Methadone Maintenance, Co-infected with HIV and Hepatitis C Journal of Substance Abuse Treatment (2006) 30:331-5.
Publication

Body:

Brown LSKritz S, Rotrosen J, Baker S, Robinson J
Relationships between State Policies and the Availability of the Services for HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections  in Substance Abuse Treatment Programs Neuropsychopharmacology (2005) 30 (Suppl.1):S87.
Publication

Body:

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D,  Muir J A, Buchan BJ, Horton T
Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA  Clinical Trials Network Field Experience. The American Journal on Addictions (2004) 13:S42-S66.
Publication

Body:

Rawlings KM, Thompson M, Farthing C, Brown LS, Racine J, Scott RC, Crawford KH, Goodwin D, Tolson JM, Williams VC, Shaefer MS
Impact of an Educational Program on Efficacy and Adherence With a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndrome (2003) 34:174-183.
Publication

 

Pages